Macular Edema With Central Retinal Vein Occlusions (DBCOND0063502)

Identifiers

Synonyms

Central Retinal Vein Occlusion With Macular Edema / Central retinal vein occlusion with macular edema (disorder)

Associated Data

Indicated Drugs and Targets

Drug	Description	Targets
Aflibercept	A vascular endothelial growth factor (VEGF) inhibitor used to treat Neovascular (Wet) Age-Related Macular Degeneration (AMD), various types of macular edema and diabetic retinopathy, and metastatic colorectal cancer	Vascular endothelial growth factor A, long formtarget Placenta growth factortarget Vascular endothelial growth factor Btarget

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT02522897	Evaluation of the "Treat-and-extend" Scheme in Patients With Retinal Vein Occlusion (RVO) With and Without LASER Treatment of Ischaemic Retinal Areas	Ranibizumab	treatment	4	unknown_status
NCT04444492	Combination of Ranibizumab and Targeted Laser Photocoagulation	Ranibizumab	treatment	3	recruiting
NCT04290195	Use of Ziv Aflibercept in Different Retinal Diseases	Aflibercept	treatment	1 / 2	completed
NCT02556723	Intravitreal Injections of Ziv-aflibercept for Macular Diseases	Aflibercept	treatment	Not Available	completed
NCT04812977	Comparison of Intravitreal Anti-VEGF Versus Combination Therapy in Central Retinal Vein Occlusion	No drug interventions	treatment	Not Available	completed
NCT02006147	Phase 1 Open-label Study to Evaluate Efficacy and Tolerability of TLC399 in Patients With Macular Edema Due to RVO	No drug interventions	treatment	1 / 2	completed
NCT05832996	Cool vs Room-temperature Artificial Tears	Polyethylene glycol 400 Propylene glycol	prevention	4	completed
NCT01870427	NEWTON: Aflibercept Injection for Previously Treated Macular Edema Associated With Central Retinal Vein Occlusions	Aflibercept	treatment	4	completed